Conserving Surgery For Breast Cancer

##plugins.themes.academic_pro.article.main##

Sameh Tebra
Sassi Bouguizene
Mohamed Bibi
Hammouda Boussen
Hedi Khairi
Noureddine Bouaouina

Abstract

Breast cancer is the first women’s cancer. Conserving surgery associated with radiotherapy, is in progress. Her indications are frequent.
The result for local control and global survival are the same as radical surgery.

Keywords:

Breast cancer, conserving surgery, , radiotherapy

##plugins.themes.academic_pro.article.details##

References

  1. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M.Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981; 305: 6-11
  2. C. Chauleur L. Vulliez , B. Trombert, D. Raoux, A. Khaddage, P. Seffert. Facteurs de risque de récidive des cancers du sein traités par chirurgie conservatrice: à propos de 254 cas. Journal de Gynécologie Obstétrique et Biologie de la Reproduction (2008) 37, 170-178
  3. Veronesi U, Cascinelli N, Mariani L.Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347 :1227-32
  4. Soler-Michel P, Courtial I, Bremond A. Reattendance of women for breast cancer screening programs. A review Rev Epidemiol Sante Publique. 2005; 53:549-67.
  5. Integration of neoadjuvant chemotherapy and surgery in the treatment of patients with breast carcinoma. Kuerer HM, Singletary SE. Breast Dis. 2001;12:69-81.
  6. Mesedi W, Benna F, Gamoudi A, Bouaouina N, Sellami D, Rahal K, Ben Youssef R, Ben Romdhane K, Ben Abdallah M, Maalej M. Conservative treatment of cancer of the breast in Tunisia] Tunis Med. 1993 ; 71:129-34.
  7. Cécile Zinzindohoué, Jean-Yves Bobin. Questions non résolues dans les indications du traitement conservateur du cancer invasif du sein. Bull Cancer. 1998;85:763-72,.
  8. Hurd TC,Sneige N,Allen PK,Strom EA,McNeese MD,Babiera GV .Impact of extensive intraductal component on recurrence and survival in patients with stage I or II breast cancer treated with breast conservation therapy.Ann Surg Oncol 1997; 4: 119-24.
  9. Darvishian F, Hajdu SI, DeRisi DC. Significance of linear extent of breast carcinoma at surgical margin.Ann Surg Oncol 2003; 10: 48- 51.
  10. DiBiase SJ, Komarnicky LT, Schwartz GF, Xie Y,Mansfield CM. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma.Cancer 1998; 82: 2212-20.
  11. Bethwaite P, Smith N, Delahunt B, Kenwright D. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.J Clin Pathol 1998; 51: 450-4.
  12. J.M. Dilhuydy, E. Bussières, P. Romestaing. La radiothérapie du sein et de la paroi thoracique : les volumes à traiter. Cancer/Radiothérapie 2001 ; 5 : 550-9
  13. Rabinovitch R, Finlayson C, Pan Z, Lewin J, Humphries S, Biffl W et alRadiographic evaluation of surgical clips is better than ultrasound for defining the lumpectomy cavity in breast boost treatment planning: a prospective clinical study. Int J Radiat Oncol Biol Phys 2000 ; 47 : 313-7.
  14. ICRU report n° 62. Prescribing, recording and reporting photon beam therapy. ICRU Bethesda, Maryland, 1999.
  15. Fletcher GH. Textbook of Radiotherapy. 3rd ed. Philadelphia : Lea and Febiger Eds; 1980.
  16. Bartelink H, Garavaglia G, Johansson KA, Mijnheer BJ, Van den Bogaert W, van Tienhoven G, et al. Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology). Radiother Oncol 1991; 22:323-6.
  17. Fourquet A, Campana F, Rosenwald JC, Vilcoq JR. Breast irradiation in the lateral decubitus position : technique of the Institut Curie. Radiother Oncol 1991;22:261-5.
  18. Grann A, Mc Cormick B, Chabner ES, Golla Mundi SV, Schupak KD, Mychalczac BR, et al. Prone breast radiotherapy in early stage breast cancer: a preliminary analysis. Int J Radiat Oncol Biol Phys 2000; 47: 319-25.
  19. Arriagada R, Mouriesse H, Sarrazin D, Clark RM, Deboer G. Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave- Roussy Institute and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 1985; 11:1751-7.
  20. Schwartzberg BS, Goates JJ, Keeler SA, Moore JA. Use of advanced breast biopsy instrumentation while performing stereotactic breast biopsies: review of 150 consecutive biopsies. J Am Coll Surg 2000; 191:9-15.
  21. Frazier RC, Kestin LL, Kini V, Martinez AA, Chen PY, Baglan KL, et al. Impact of boost technique on outcome in early-stage breast cancer patients treated with breast conserving therapy. Am J Clin Oncol 2001; 2426-32.
  22. Mangold CA, Rijnders A, Georg D, Van Limbergen E, Potter R, Huyskens D. Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system. Radiother Oncol 2001; 58:43-51.
  23. Resch A, Potter R,Van Limbergen E, Biber E, Klein T, Fellner C, et al. Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer. Radiother Oncol 2002; 63:47-58.
  24. Krishnan EC, Krishnan L, Cytaki EP, Woolf CD, Henry MM, Lin F, et al. Advantages of an immediate interstitial boost dose in conservative treatment of breast cancer. Int J Radiat Oncol Biol Phys 1990;18:419-24.
  25. A. Fourquet, B. Cutuli, E. Luporsi, L. Mauriac, J.R. Garbay, S. Giard et al.Standards, Options et Recommandations 2001 pour la radiothérapie des patientes atteintes d'un cancer du sein infiltrant non métastatique, mise à jour. Cancer/Radiother 2002 ; 6 : 238-58
  26. Buchholz TA, Austin Seymour MM, Moe RE, Ellis GK, Livingston RB, Pelton JG, et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 1993; 26:23-35.
  27. Slotman BJ, Meyer OW, Njo KH, Karim AB. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol 1994; 30:206-12.
  28. McCormick B, Begg CB, Norton L, Yao TJ, Kinne D. Timing of radiotherapy in the treatment of early-stage breast cancer . J Clin Oncol 1993; 11:191-3.
  29. Buzdar AU, Kau SW, Smith TL, Ames F, Singletary E, Strom E, et al. The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer 1993; 71:3680-4
  30. Toledano A, Garaud P, Serin D, Fourquet A, Bosset JF, Miny-Buffet J, Favre A, Azria D, Body G, Le Floch O, Calais G. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities. Cancer Radiother. 2006; 10:158-67.
  31. Early breast cancer trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomised trials. N Engl J Med 1995; 333: 1444-55.
  32. Arriagada R, G. E M. Rochard F. Contesso G for the InstituteGustave-Roussy. Breast Cancer Group. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol 1996:14: 1558- 64
  33. Van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet Fetal. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.Eur J Cancer 1992; 28:801-5.
  34. 34. Jacobson JA, Danforth DN, Kenneth HC, d'AngeloT, Steinberg SM. Pierce L. Ten-year of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl JMed 1995; 332: 907-11
  35. 35. Fisher ER; Anderson S, Redmond C, Fisher B.Pathologic findings from the national surgical adjuvant breast project protocol B-06. Cancer- 1993; 71: 2507-14
  36. Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary issection for node negative breast cancer. J Natl cancer Inst 1992; 4:683-9
  37. Hannoun-Levi J. M. ; Marsiglia H. ; Garbey J. R. ; Gerard J. P.Irradiation partielle du sein : pourquoi, comment. Cancer Radiothér 2003;7: 200-209.
  38. E.Touboul, F.Pene, B.Blaska-Jaulerry, L. Vitu-Loas, L. Schwart, M. Schilenger, A. Laugier. Revue des résultats et étude critique de la chirurgicale partielle conservatrice associée à une radiothérapie post-opératoire dans les cancers du sein opérables d'emblée stades I et II. Bull. Cancer 1992; 79: 315-345.
  39. L. Benoit, C. Franceschini, A. Margarot, L. Arnould, J. Fraisse, J. Cuisenier .Traitement conservateur du cancer du sein : proposition d'une incision cutanée combinée pour un meilleur résultat esthétique. Annales de chirurgie 2004; 129 :310-312
  40. Clough KB, Lewis JS, Couturaud B, Fitoussi A, Nos C, Falcou MC. Oncoplastic techniques allow extensive resections for breastconserving therapy of breast carcinomas. Ann Surg 2003; 237: 26- 34.
  41. Kaur N, Petit JY, Rietjens M et al. Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer.Ann Surg Oncol 2005; 12: 539-45.
  42. Clough KB, Nos C, Salmon RJ, Soussaline M,Durand JC.Conservative treatment of breast cancers by mammoplasty and irradiation: a new approach to lower quadrant tumors.Plast Reconstr Surg 1995; 96: 363-70.
  43. Achard E, Salmon RJ. Traitement des cancers des quadrants inférieurs du sein par plastie mammaire de réduction. E mémoires de l'Académie Nationale de Chirurgie, 2006; 5 : 41-44
  44. Giacalone P-L, P. Roger , O. Dubon , N. El Gareh , J.-P. Daurés , F. Laffargue.Traitement conservateur des cancers du sein : zonectomie vs oncoplastie. Étude prospective à propos de 99 patientes.Ann chir 2006; 131 256-261.
  45. E. Delay, J. Gosset, G. Toussoun, T. Delaporte, M. DelbaereEfficacité du lipomodelage pour la correction des séquelles du traitement conservateur du cancer du sein. Ann Chir Plast Esth 2008; 53: 153-168.